Form D · Biotechnology
Zymeworks Inc.
Middletown, DE · CIK 0001937653
Offering snapshot reported Jan 3, 2024 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2024 | Initial | $49,999,993 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-501459
The Issuer issued and sold 5,086,521 prefunded warrants to purchase shares at an exercise price of $0.0001 per share. The purchase price of the prefunded warrants was $9.8299 per security.
Source: Form D, filed Jan 3, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris Astle | Executive |
| Carlos Campoy | Director |
| Troy M. Cox | Director |
| Nancy Davidson | Director |
| Kenneth Galbraith | Director, Executive |
| Kenneth Hillan | Director |
| Susan Mahony | Director |
| Derek Miller | Director |
| Paul Moore | Executive |
| Kelvin Neu | Director |
| Hollings C. Renton | Director |
| Jeffrey Smith | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
108 Patriot Drive, Suite A
Middletown, DE, 19709
Middletown, DE, 19709